Fall 2026, Issue 5 - read it below or see a PDF of this issue.
Entering the Final Lap in CAMEO
Together we have reached many milestones. It’s exciting to let you know that enrollment for CAMEO’s Phase 2 is complete. This is something to celebrate together! Every participant counts.
In this issue, you can see the progress we have made together. As of July-August 2026:
1269 children and adolescents are enrolled in Phase 1.
607 are now in Phase 2.
In Phase 2, 64% are boys and 36% are girls.
In Phase 2, the average age is 12.7.
Looking for Healing in CAMEO
Because there is no cure for Crohn’s disease, the goal of treatment is to heal the bowel. But why do some children living with Crohn’s disease, once given a common treatment, have intestinal healing and others do not?
Through the CAMEO study, we hope participants like you or your child show us some answers to this question. You make a difference every day in helping future pediatric patients achieve a faster path to remission from Crohn’s disease. Things that you or your child do in CAMEO after a year of treatment, like a colonoscopy and MRI, help us better understand how the bowel heals over time.
After treatment, some patients may feel better. But fewer symptoms of Crohn’s disease do not predict healing alone. Someone could feel better but still have an inflamed bowel. The MRI and colonoscopy help us better understand healing. That may help us better treat Crohn’s disease in children in the future. Thank you for participating in these important activities in CAMEO!
The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. CAMEO (Clinical, imaging, and endoscopic outcomes of children newly diagnosed with Crohn’s disease) is funded by the National Institutes of Health (NIH) through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Research reported in this publication was supported under Award Number 1U01DK134356-01. cameostudy.org